重症病人服用維生素D 是否能改善死亡率?Dose Vitamin D Administration improve Mortality in Critically ill patient?

420 1 71

2023-12-18 已刊登
新刊登 綜 整 預防/治療/介入類型

作  者

張庭碩* 柯家媛 章雅茜

文章類別

A 類:實證健康照護綜整

問題類型

治療/預防性問題

健康狀況

胸腔暨重症加護醫學 (Pulmonary and Critical Care Medicine)  

治療/介入措施

其他(Others) - 服用維生素D

專長類別

急重症暨手術護理

中文關鍵詞

#重症 #維生素D #死亡率

英文關鍵詞

# Critically ill # Vitamin D # Mortality

機構名稱

奇美醫療財團法人奇美醫院

申請單位

內科加護病房

中文摘要

形成臨床提問:
加護病房重症病人常見血中維生素D濃度明顯不足,維生素D是人體免疫調節、抗菌發炎、鈣磷調節的重要內分泌物質,研究指出重症病人維生素D濃度不足與住院死亡率及預後可能有關,為探討高劑量維生素D的補充是否能夠降低重症加護病人的死亡率,故藉由實證文獻搜尋重症病人服用高劑量維生素D是否能改善死亡率。
文獻搜尋的方法與分析:
本文以臨床情境提出問題,設定 P:Critical ill、I:Vitamin D、C:none or placebo、O:Mortality為關鍵字,以MeSH term搜尋同義字,將關鍵字與同義字進行聯集與交集,截至2022年8月31日為止,搜尋PubMed、CINAHL/ MEDLINE、Cochrane Library及華藝線上圖書館中英文資料庫,設定語言為中文及英文,文獻類型為Meta-analysis、Systemic review(SR)、Randomized controlled trial(RCT),得到182篇並刪除重覆、與PICO設定不符、研究設計或措施不符文獻,最後納入3篇RCT評讀。
文獻的品質評讀:
以新版CASP進行文獻評讀,3篇RCT文獻CEBM證據等級為2B(治療型),收錄文章PICO皆符合本文設定,研究對象為18歲以上收住加護病房的重症成人,介入措施為入住加護病房後早期經由腸道給予高劑量維生素D,對照組給予安慰劑,比較兩組病人的死亡率,3篇文獻在研究設計上無選樣偏差及流失偏差,僅一篇文獻未提及執行雙盲之相關論述,研究結果在住院死亡率p >.05,顯示重症病人服用維生素D並沒有顯著降低死亡率。
結果、結論與建議:
重症病人入住加護病房早期服用高劑量維生素D能顯著提升血中25(OH)D濃度,但並無顯著降低死亡率。對於維生素D嚴重缺乏小於12ng/mL的重症病人,高劑量補充維生素D對於病人氣切的需求有顯著差異。當大量服用維生素D可能造成病人腸胃道不適及巨額自費,建議仍可先依循臨床治療指引建議處理,若病況仍未改善再評估使用。因此,藉由實證文獻搜尋,並沒有足夠證據支持維生素 D能改善死亡率,期待未來有更多嚴謹的臨床隨機試驗提供我們參考。

英文摘要

Ask an answerable question (PICO):
It is common for critically ill patients with Vitamin D deficiency in the intensive care unit. Vitamin D is the endocrine hormone for human immune regulation, antibacterial, inflammatory suppression, and balance of calcium and phosphorus. Vitamin D deficiency in critically ill patients may be related to in-hospital mortality and prognosis. In order to find out whether high dosage Vitamin D administration reduce the mortality of critically ill patients in intensive care unit, we searched for empirical literature to investigate whether high-dose vitamin D administration in critically ill patients can improve mortality.
The Method and Analysis of Literature Review:
Based on the evidence, the five steps form an answerable question: “Does Vitamin D Administration improve Mortality in Critically ill patient?” The PICOs as below are P: Critically ill, I: Vitamin D, C: none or placebo and O: Mortality. PICO keywords, synonyms, MeSH term and Boolean logic were used to search for Chinese and English data before August 31, 2022 in, PubMed, CINAHL/MEDLINE, Cochrane library and Hua Yi online library. The literature was based on systematic review (SR) and randomized controlled trials (RCT) with English and Chinese literature. Initially, 182 studies were searched, duplicates were removed, titles and abstracts were read, and 3 RCTs were finally included for review.
Critical Appraisal:
The new version of CASP was used for literature review. and the CEBM evidence level of the three RCTs was 2B (therapeutic type). All three articles were met the settings of PICO. High-dose vitamin D was given through gastrointestinal tract after intervention group transfer to ICU, and the control group was given placebo. Three studies were conducted with no selection bias or attrition bias in their study designs, while only one study did not mention any relevant discussions on implementing double-blind procedures. The p-value of mortality rates were p >.05, showing that taking vitamin D in critically ill patients did not significantly reduce mortality.
Results, Conclusions and Recommendations:
There is no significant differences for critically ill patient taking Vitamin D as soon as possible after admitted in the ICU to improve mortality but significantly increased the serum 25(OH)D level. It was significant difference in need for tracheostomy for patient with severe Vitamin D deficiency <12ng/dl taking high-dose Vitamin D. Also, high-dose Vitamin D administration could result in gastrointestinal uncomfortable and economic burden. We suggest Self–paid Vitamin D given when poor response by treating as Clinical guideline and protocol. Therefore, through empirical literature search, there is not enough evidence to support that Vitamin D can improve mortality. We look forward to more rigorous clinical randomized trials for our reference in the future.